Financial Markets collage Northcote Internet Logo
transparent spacer
transparent spacer
 >   > 
transparent spacer
 
curve on page transparent spacer
Northcote Internet Ltd provide Investor Relations Webcasting. Click Here
 
transparent spacer transparent spacer transparent spacer transparent spacer
transparent spacer Home menu end curves
Newsletter
transparent spacer
transparent spacer About Us menu end curves
transparent spacer
transparent spacer Donations menu end curves
transparent spacer
transparent spacer Registrars menu end curves
transparent spacer
transparent spacer Spread Betting menu end curves
transparent spacer
transparent spacer Submit links menu end curves
transparent spacer
transparent spacer transparent spacer
transparent spacer transparent spacer transparent spacer
transparent spacer
transparent spacer
navigation curves Home navigation curves navigation curves By Index navigation curves navigation curves By Sector navigation curves navigation curves Alphabetically navigation curves navigation curves Search navigation curves navigation curves My Portfolio navigation curves
 >  > 
 
Follow northcote_b on Twitter
BTG plc
transparent spacer
transparent spacer
transparent spacer
Company Information
Address: 5 Fleet Place
London
EC4M 7RD
Index: To continue showing the FTSE index and sector information we need a license from FTSE International Limited. Will anyone sponsor us to return this data to the site.
Tel: +44 (0)20 7575 0000 Sector:
Fax: +44 (0)20 7575 0010
E-Mail: info@btgplc.com Epic:
Secretary: Paul Mussenden    
Registrar: Capita Registrars Beckenham Ltd Updated: 15/01/2014

Company Overview

BTG is a world leader in the commercialisation of novel technologies, operating from offices in Europe, North America and Japan. Through a combination of science and technology, patent and legal expertise and business know-how BTG has brought to market such devices as the hovercraft, the commercial safety needle, magnetic resonance imaging (MRI) and interferons (proteins with an ability to prevent viruses replicating in the body). In the week beginning 11 July, subsidiary Provensis received approval from the US Food and Drug Administration (FDA) to resume clinical development of Varisolve®, which is being developed as a massively important microfoam treatment for varicose veins.

 
Annual Reports
Description Report Date Published Current  
bullet point Annual Report 2013 in PDF 31/03/2013 17/05/2013 Yes  
bullet point Annual Report 2012 in PDF 31/03/2012 18/05/2012 No  
bullet point Annual Report 2011 in PDF 31/03/2011 24/05/2011 No  
bullet point Annual Report 2010 in PDF 31/03/2010 20/05/2010 No  
bullet point Annual Report 2009 in PDF 31/03/2009 13/05/2009 No  
bullet point Annual Report 2008 in PDF 31/03/2008 16/05/2008 No  
bullet point Annual Report 2007 in PDF 31/03/2007 23/05/2007 No  
bullet point Annual Report 2006 in PDF 31/03/2006 24/05/2006 No  
bullet point Annual Report 2005 in PDF (0.37Mb) 31/03/2005 25/05/2005 No  
bullet point Annual Report 2004 in PDF (0.6Mb) 31/03/2004 26/05/2004 No  
bullet point Annual Report 2003 in PDF (0.62Mb) 31/03/2003 29/05/2003 No  
bullet point Annual Report 2002 in PDF (0.78Mb) 31/03/2002 30/05/2002 No  
 
Interim Reports
Description Report Date Published Current  
bullet point Interim Results 2013 in PDF 30/09/2013 11/11/2013 Yes  
bullet point Interim Results 2012 in PDF 30/09/2012 7/11/2012 No  
bullet point Interim Results 2011 in PDF 30/09/2011 16/11/2011 No  
bullet point Interim Results 2010 in PDF 30/09/2010 3/11/2010 No  
bullet point Interim Results 2009 in PDF 30/09/2009 4/11/2009 No  
bullet point Interim Results 2008 in PDF 30/09/2008 11/11/2008 No  
bullet point Interim Results 2007 in PDF 30/09/2007 6/11/2007 No  
bullet point Interim Results 2006 in PDF 30/09/2006 8/11/2006 No  
bullet point Interim Results 2005 in PDF 30/09/2005 9/11/2005 No  
bullet point Interim Results 2004 in PDF (0.26Mb) 30/09/2004 11/11/2004 No  
bullet point Interim Results 2003 in PDF 30/09/2003 3/12/2003 No  
bullet point Interim Results 2002 in PDF 30/09/2002 3/12/2002 No  
 
Other Links
Description
bullet point Home
bullet point Site Map
bullet point Investor Relations
bullet point Events Calendar
bullet point Results Index
bullet point Press Releases
bullet point Contacts
To continue showing the FTSE index and sector information we need a license from FTSE International Limited. Will anyone sponsor us to return this data to the site.


transparent spacer